跳至主要内容
临床试验/ISRCTN14552440
ISRCTN14552440已完成2 期

Salbutamol for Analgesia in Renal Colic (SARC) v1.0: a prospective, randomised, placebo-controlled Phase II trial

Derby Hospitals NHS Foundation Trust0 个研究点目标入组 148 人开始时间: 2019年7月22日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
148

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Subjects capable of giving informed consent
  • 2. Age > = 18
  • 3. Working diagnosis of renal colic, as suggested by severe flank/unilateral abdominal pain, +/- radiating to suprapubic/groin area
  • 4. Experiencing severe pain with a requirement for intravenous analgesia

排除标准

  • Current participant exclusion criteria as of 19/02/2020:
  • 1. Abdominal aortic aneurysm not yet excluded and participant aged > = 50
  • 2. Ectopic pregnancy not yet excluded in a female of child-bearing potential
  • 3. Currently actively taking part in another CTIMP
  • 4. Previous participant in this trial
  • 5. Unable to understand verbal and/or written information in English
  • 6. Known allergy to salbutamol
  • 7. Evidence of sepsis or clinical suspicion of urinary tract infection
  • 8. Serum potassium < 3.7mmol/l
  • 9. Concomitant use of: beta blockers (including eye drops); prolonged release opiates; long-acting ß-agonists
  • 10. Use of short-acting ß2-agonists within the 6 hours preceding presentation to the emergency department
  • 11. Current arrhythmia
  • 12. History of any of:
  • 12.1. Ischaemic heart disease
  • 12.2. Arrhythmogenic heart disease
  • 12.3. Valvular heart disease
  • 12.4. Unilateral kidney
  • 13. Any other contraindication to the use of salbutamol
  • Previous participant exclusion criteria:
  • 1. Abdominal aortic aneurysm not yet excluded and participant aged > = 50
  • 2. Ectopic pregnancy not yet excluded in a female of child-bearing potential
  • 3. Currently actively taking part in another CTIMP
  • 4. Previous participant in this trial
  • 5. Unable to understand verbal and/or written information in English
  • 6. Known allergy to salbutamol
  • 7. Evidence of sepsis or clinical suspicion of urinary tract infection
  • 8. Serum potassium < 3.7mmol/l as measured on point-of-care” venous blood gas
  • 9. Concomitant use of: beta blockers (including eye drops); prolonged release opiates; long-acting ß-agonists
  • 10. Use of short-acting ß2-agonists within the 6 hours preceding presentation to the emergency department
  • 11. Current arrhythmia
  • 12. History of any of:
  • 12.1. Ischaemic heart disease
  • 12.2. Arrhythmogenic heart disease
  • 12.3. Valvular heart disease
  • 12.4. Unilateral kidney
  • 13. Any other contraindication to the use of salbutamol

研究者

发起方
Derby Hospitals NHS Foundation Trust

相似试验